MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/100/0.1/20.09.24 Stock MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/100/0.1/20.09.24
Add to a list
To use this feature you must be a member
Log inSign up

MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/100/0.1/20.09.24 Stock

Warrant

DE000ME1FUP2

Market Closed - Börse Stuttgart 14:23:02 2024-05-31 EDT
0.022 EUR +29.41% Intraday chart for MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/100/0.1/20.09.24
1 month+10.00%
3 months+83.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart ASTRAZENECA PLC
Chart MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/100/0.1/20.09.24

Latest news about ASTRAZENECA PLC

Presage Biosciences Announces New Pharma Partnership to Evaluate Novel Immuno-Oncology Drug Combinations with CIVO® Technology PR
New analysis of Phase II data at AACR assesses ImaginAb's investigational CD8 ImmunoPET technology's ability to predict response in immunotherapy PR
Invitae Announces Partnership for Real-World Data Sharing to Inform Rare Cancer Research PR
Baili Announces Clinical Trial Collaboration to Evaluate SI-B001, an EGFR x HER3 bispecific Antibody, in Combination with Tagrisso® in Patients with Non-Small Cell Lung Cancer PR
More news

Quotes 5-day view

Date Price Change
24-05-31 0.022 +29.41%
24-05-30 0.017 -.--%
24-05-29 0.017 +183.33%
24-05-28 0.006 -45.45%
24-05-27 0.011 -56.00%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 02:23 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ASTRAZENECA PLC
Issuer Morgan Stanley
WKN ME1FUP
ISINDE000ME1FUP2
Date issued 2023-10-03
Strike 100 $
Maturity 2024-09-20 (110 Days)
Parity 10 : 1
Emission price 0.09 €
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.063 €
Lowest since issue 0.001 €
Delta0.07x
Omega 15.48
Premium28.61x
Gearing228.33x
Moneyness 0.7802
Difference Strike 21.98 $
Difference Strike %+21.98%
Spread 0.017 €
Spread %42.50%
Theoretical value 0.0315
Implied Volatility 28.12 %
Total Loss Probability 94.98 %
Intrinsic value 0.000000
Present value 0.0315
Break even 100.34 €
Theta-0x
Vega0.01x
Rho0x

Company Profile

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
More about the company

Ratings for AstraZeneca PLC

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: AstraZeneca PLC

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
155.1 USD
Average target price
172 USD
Spread / Average Target
+10.90%
Consensus
  1. Stock Market
  2. Warrants
  3. Warrant